Chloe Botaine

The movement toward off-the-shelf immunotherapy is solving the scalability issues that have long limited the reach of personalized autologous cellular treatments in oncology clinics. While chimeric antigen receptor (CAR) T-cell therapies have established a foundational success in treating

The diagnostic reality for nearly ten percent of patients with advanced solid tumors involves a debilitating accumulation of abdominal fluid that traditionally signals the final, most resistant stage of oncological progression. For years, this fluid, known as malignant ascites, was treated

Implementation of standardized safety evaluations is becoming a necessity for healthcare organizations before any artificial intelligence tool enters a live clinical workflow. A landmark study from the Icahn School of Medicine at Mount Sinai has shed light on the precarious intersection of

The resignation of FDA Commissioner Marty Makary on May 12, 2026, effectively unblocked the administrative queue for scheduling critical drug and device advisory meetings. This shift signals a broader effort to revitalize a system that has long been the backbone of regulatory transparency. The

A comparative study using a trastuzumab biosimilar revealed that automation can reduce the average variability in glycan profiling by twenty-eight percent compared to manual processing. This discovery comes at a critical time in 2026, as the pharmaceutical sector grapples with the increasing

Genomic literacy is not evenly distributed across the population, with significant disparities in awareness based on religion, education, and ancestral background. This observation serves as a cornerstone for Singapore’s latest health initiative, which shifts the focus of genetic medicine toward

The design flexibility of bioprinted vascular platforms allows for the customization of cell ratios and geometries to meet the specific needs of individual patients. This high level of precision is particularly vital in 2026, as the medical community continues to face the mounting challenge of

Desktop DNA synthesis machines are combining with AI-driven design tools to lower the technical barriers required for synthesizing dangerous biological sequences in non-traditional settings. This technological synergy, while fueling unprecedented advancements in medicine and sustainable

Biohybrid systems integrate living biological components like Spirulina algae with synthetic iron oxide to create steerable platforms for photothermal therapy. This innovative approach addresses a long-standing challenge in oncology, where traditional chemotherapy often acts like a blunt

The inaugural Singapore Engineering Biology Week in October 2026 will showcase the nation’s progress in research translation and the bioeconomy. This landmark event serves as the backdrop for the unveiling of the National Centre for Engineering Biology, a specialized facility hosted at the National